CAU
AMGN icon

Caxton Associates (UK)’s Amgen AMGN Stock Holding History

Caxton Associates (UK)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-910
Closed -$254K – 689
2025
Q2 		$254K Sell
910
-806
-47% -$228K 0.01% 578
2025
Q1 		$535K Buy
+1,716
New +$507K 0.02% 463

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caxton Associates (UK)'s AMGN Position: Q3 2025 in Review

Caxton Associates (UK) sold out of Amgen (AMGN) in Q3 2025, closing a stake of 910 shares — an estimated $254K sold.

Caxton Associates (UK) first reported a position in AMGN in Q1 2025 and held it in 2 quarters. The position peaked at $535K in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Caxton Associates (UK) reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 910 Amgen shares in Q3 2025, an estimated $254K.
  • Caxton Associates (UK) first reported a position in Amgen in Q1 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Amgen position peaked at $535K in Q1 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.